Sign in

CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company

ACHIEVE LIFE SCIENCES, INC.

Sign in to watch
Ticker
ACHV
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
954343413
Phone
425-686-1500
Business address
22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
Former names
ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations
  3. 4 Derivatives Options or other derivatives
  4. 3 Insider Initial Statement of Ownership
  5. 8-K Event Executive or director change
  6. 4 Open-market sale Director sold 20,626 shares at $8.49 ($175,177)
  7. 144 Insider Sale of Securities
  8. SCHEDULE 13G Stake Statement of Beneficial Ownership
  9. 8-K Event Other events
  10. 424B5 Offering Prospectus
  11. SCHEDULE 13G Stake Statement of Beneficial Ownership
  12. 10-Q Report Quarterly Report
  13. 8-K Event Results of operations
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 1 of 68 · 1,358 filings